$10.83
N/A
Last update: Nov 4, 4:00 PM
Keros Therapeutics Inc
KROSNASDAQ
The average analyst price target for Keros Therapeutics is $25.54, 135.8% above the current price. Of 13 analysts, 6 rate it Buy and 7 Hold. Targets range from $15 to $77. The latest change came on Aug 4, 2026, when Wells Fargo lowered its price target on Keros Therapeutics from $20 to $18 and kept an Overweight rating.
Price Target Range — 11 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
